Mesothelioma is nothing but a cancer of the mesothelium. It affects the abdominal cavity, chest and the region surrounding the heart. E 'fundamental to the structure of most of the internal organs of the body. Mesothelioma is usually difficult to diagnose and treat because of its unusual nature.
Cancer is essentially on the growth of body cells or specific tissues. Here is the trigger factor is exposure to asbestos, a material used in many worksEnvironments. Therefore, it is also known as asbestos lung cancer. However, it may also use other substances, such as radiation, are activated Erionite [fibrous silicate] and thorium. People who are particles that contain asbestos are exposed to very susceptible to this disease. E 'especially for people who work in construction, shipbuilding, automobile and other manufacturing industries, where there is exposure to asbestos is widespread. Therefore, men tend to be most affected, becauseThe presence of asbestos in industrial settings, however, morbidity can be observed in women.
The latency of mesothelioma is up to 30 to 40 years, and many people previously exposed to asbestos are now showing symptoms. This means an average of mesothelioma patients is between 50 to 70 years. The risk of mesothelioma increases with increasing age, but the disease can make the appearance at any age.
Symptoms may include, but are not limited to respiratory distress, duration of a cough and pneumonia. Moreover, the symptoms are often mistaken for less serious illnesses. Single pleural mesothelioma is possible with some fluid between the lung lining and chest cavity, but this could easily accumulate detected through a chest x-ray.
Radiotherapy is one of the best treatment option mesothelioma. Even radiotherapy in combination with chemotherapy may be tried for the diagnosis of mesothelioma. All in all,> Mesothelioma is a life-threatening and the disease can not be left in place. The first one is detected, the greater the likelihood of a patient are the fight against this deadly disease.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น